PASSERI DANIEL R has filed 3 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 450000 shares of Cue Biopharma, Inc. ($CUE) on March 21, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 21, 2025 | Cue Biopharma, Inc. | $CUE | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 56,328,348 | 9999.99% | 0.80% |
| Dec. 16, 2024 | Cue Biopharma, Inc. | $CUE | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | P | Common Stock | 30000 | $1.03 | 164,578.0000 | 51,229,701 | 22.29% | 0.06% |
| March 6, 2024 | Cue Biopharma, Inc. | $CUE | PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 45,754,794 | 9999.99% | 0.87% |